STELITANO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 845
AS - Asia 708
EU - Europa 618
SA - Sud America 155
AF - Africa 29
OC - Oceania 8
Totale 2.363
Nazione #
US - Stati Uniti d'America 815
CN - Cina 284
SG - Singapore 165
IE - Irlanda 142
BR - Brasile 124
RU - Federazione Russa 124
HK - Hong Kong 123
IT - Italia 118
DE - Germania 64
GB - Regno Unito 48
VN - Vietnam 40
IN - India 35
FI - Finlandia 29
AT - Austria 20
ZA - Sudafrica 16
CA - Canada 13
FR - Francia 13
MX - Messico 13
AR - Argentina 12
BD - Bangladesh 11
SE - Svezia 11
ES - Italia 9
JP - Giappone 9
NL - Olanda 9
EG - Egitto 8
PL - Polonia 8
AU - Australia 7
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
LT - Lituania 5
TR - Turchia 5
UA - Ucraina 5
CL - Cile 4
ID - Indonesia 4
IQ - Iraq 4
KR - Corea 4
CO - Colombia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PH - Filippine 3
VE - Venezuela 3
HN - Honduras 2
JO - Giordania 2
KW - Kuwait 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BE - Belgio 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
PY - Paraguay 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.363
Città #
Hong Kong 120
Dublin 112
Ashburn 98
Dallas 89
Singapore 78
Beijing 74
Chandler 71
Boardman 54
Los Angeles 37
Shanghai 34
Munich 32
New York 29
Pavia 26
Redondo Beach 24
Helsinki 21
Ann Arbor 20
Moscow 20
Milan 19
Ho Chi Minh City 17
Lawrence 15
Princeton 15
The Dalles 15
Vienna 15
Medford 14
São Paulo 14
Nanjing 12
Chicago 11
Santa Clara 11
Shenyang 11
Menlo Park 9
Hanoi 8
Johannesburg 8
Nanchang 8
Nuremberg 8
Turku 8
Wilmington 8
Brooklyn 7
Cape Town 7
Corteolona 7
Dearborn 7
Florence 7
Hyderabad 7
Stockholm 7
Tokyo 7
Washington 7
Atlanta 6
Boston 6
Buffalo 6
Cinisello Balsamo 6
Guangzhou 6
Warsaw 6
Changsha 5
Columbus 5
Denver 5
Dhaka 5
Fairfield 5
Falkenstein 5
Hangzhou 5
London 5
Montreal 5
Shenzhen 5
Turin 5
Worcester Park 5
Brasília 4
Cagliari 4
Chennai 4
Chongqing 4
Coventry 4
Delhi 4
Haiphong 4
Istanbul 4
Jiaxing 4
Palermo 4
San Genesio ed Uniti 4
Seattle 4
Secaucus 4
Tianjin 4
Amsterdam 3
Armidale 3
Brighton 3
Charlotte 3
Curitiba 3
Dubai 3
Fortaleza 3
Guarulhos 3
Hebei 3
Hefei 3
Houston 3
Melbourne 3
Mexico City 3
Mumbai 3
New Delhi 3
Norwalk 3
Norwich 3
Nürnberg 3
Orem 3
Ottawa 3
Palma 3
Poplar 3
Querétaro 3
Totale 1.449
Nome #
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents 105
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 101
Characterization of mycobacterial enzymes as targets for potential antitubercular compounds. 101
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents 88
Targeting iron uptake pathway for the development of novel antitubercular drugs. 85
Improve protection to prevent infections: application of reverse vaccinology against cystic fibrosis pathogens. 85
From virulence factors to drug development: MbtI as an effective Mycobacterium tuberculosis target 78
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 75
Mycobacterium abscessus siderophores biosynthesis as a target to inhibit the iron uptake mechanism 74
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 73
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MbtI from Mycobacterium tuberculosis. 72
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 68
Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation 67
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. 65
Multi-target antitubercular drugs: identification of novel dual MbtI and MptpB inhibitors. 65
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 64
Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach 63
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand? 58
Structural insights for the development of novel antituberculars targeting the iron uptake pathway. 58
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 57
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents 57
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 56
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 55
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 55
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 55
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 54
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 51
Synthesis, characterization, and biological evaluation of new derivatives targeting MbtI as antitubercular agents 48
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI. 47
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis MbtI and MPtpB 45
Investigating the inhibition mechanism and catalytic cycle of MbtI, the salicylate synthase from Mycobacterium tuberculosis. 44
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 44
Phage therapy: an alternative approach to combating multi-drug-resistant bacterial infections in cystic fibrosis 43
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy 42
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 42
Artificial Intuition and accelerating the process of antimicrobial drug discovery 40
Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections 37
Chapter 28. Multi-target Compounds for Tuberculosis 35
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors. 27
Polymersomes as selective drug delivery carriers for innovative anti-TB agents. 26
Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity. 24
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity 23
Structural and biochemical investigations into the binding mode of furan-based inhibitors of MbtI from M. tuberculosis. 21
Totale 2.473
Categoria #
all - tutte 11.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 2 3 11 2 0 1 2
2021/2022109 0 0 0 40 2 1 4 4 12 8 7 31
2022/2023283 18 29 11 10 14 20 0 21 141 1 15 3
2023/2024325 26 52 19 41 24 55 31 16 1 22 9 29
2024/2025763 37 55 20 12 31 21 65 52 205 41 73 151
2025/2026853 145 89 186 197 208 28 0 0 0 0 0 0
Totale 2.473